WILLOWBROOK, Ill., April 27, 2020 /PRNewswire/ -- Pharmazz, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat patients in critical care, ...

Thrombolytic agents, including tenecteplase, are generally used within 4.5 hours after the onset of stroke symptoms. Information on whether tenecteplase confers benefit beyond 4.5 hours is limited. We ...

The most common scale used to evaluate outcome of neurosurgical procedures, the modified rankin scale (mRS) – does not measure what is commonly assumed, concludes a study conducted at the Department ...

Endovascular thrombectomy alone was noninferior to thrombectomy plus thrombolysis with alteplase in terms of functional outcome for patients with large-vessel acute ischemic stroke in a new Chinese ...

The effects and risks of endovascular thrombectomy 6 to 24 hours after stroke onset due to basilar-artery occlusion have not been extensively studied. In a trial conducted over a 5-year period in ...

Please provide your email address to receive an email when new articles are posted on . The odds ratio of a worse modified Rankin score in the asymptomatic hemorrhagic infarction and subarachnoid ...

Lower target systolic BP after successful endovascular therapy demonstrated a signal of harm and only a marginal probability of benefit toward infarct volume and disability, a speaker reported. The ...

Adverse nonmotor outcomes are prevalent in younger adults up to 6 months after stroke — even in those with favorable functional recovery scores on standard scales. In a prospective trial of about 500 ...

The most common scale used to evaluate outcome of neurosurgical procedures, the modified rankin scale (mRS) -- does not measure what is commonly assumed, concludes a study conducted at the Department ...

Surgery has become a volatile field during the past few years, with study after study challenging prevailing treatment practices. For example, surgical treatment of acute appendicitis and arthroscopic ...